Seth Alpna 4
4 · Keros Therapeutics, Inc. · Filed May 3, 2023
Insider Transaction Report
Form 4
Seth Alpna
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-01+20,000→ 20,000 totalExercise: $46.07Exp: 2033-04-30→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]One-twelfth (1/12th) of the shares subject to the option shall vest in equal quarterly installments commencing on August 1, 2023, subject to the Reporting Person continuing to provide service through each such date.